Distribution of nickel and chromium containing particles from tattoo needle wear in humans and its possible impact on allergic reactions.


Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
27 08 2019
Historique:
received: 16 05 2019
accepted: 09 08 2019
entrez: 28 8 2019
pubmed: 28 8 2019
medline: 25 2 2020
Statut: epublish

Résumé

Allergic reactions to tattoos are amongst the most common side effects occurring with this permanent deposition of pigments into the dermal skin layer. The characterization of such pigments and their distribution has been investigated in recent decades. The health impact of tattoo equipment on the extensive number of people with inked skin has been the focus of neither research nor medical diagnostics. Although tattoo needles contain high amounts of sensitizing elements like nickel (Ni) and chromium (Cr), their influence on metal deposition in skin has never been investigated. Here, we report the deposition of nano- and micrometer sized tattoo needle wear particles in human skin that translocate to lymph nodes. Usually tattoo needles contain nickel (6-8%) and chromium (15-20%) both of which prompt a high rate of sensitization in the general population. As verified in pig skin, wear significantly increased upon tattooing with the suspected abrasive titanium dioxide white when compared to carbon black pigment. Additionally, scanning electron microscopy of the tattoo needle revealed a high wear after tattooing with ink containing titanium dioxide. The investigation of a skin biopsy obtained from a nickel sensitized patient with type IV allergy toward a tattoo showed both wear particles and iron pigments contaminated with nickel. Previously, the virtually inevitable nickel contamination of iron pigments was suspected to be responsible for nickel-driven tattoo allergies. The evidence from our study clearly points to an additional entry of nickel to both skin and lymph nodes originating from tattoo needle wear with an as yet to be assessed impact on tattoo allergy formation and systemic sensitization.

Sections du résumé

BACKGROUND
Allergic reactions to tattoos are amongst the most common side effects occurring with this permanent deposition of pigments into the dermal skin layer. The characterization of such pigments and their distribution has been investigated in recent decades. The health impact of tattoo equipment on the extensive number of people with inked skin has been the focus of neither research nor medical diagnostics. Although tattoo needles contain high amounts of sensitizing elements like nickel (Ni) and chromium (Cr), their influence on metal deposition in skin has never been investigated.
RESULTS
Here, we report the deposition of nano- and micrometer sized tattoo needle wear particles in human skin that translocate to lymph nodes. Usually tattoo needles contain nickel (6-8%) and chromium (15-20%) both of which prompt a high rate of sensitization in the general population. As verified in pig skin, wear significantly increased upon tattooing with the suspected abrasive titanium dioxide white when compared to carbon black pigment. Additionally, scanning electron microscopy of the tattoo needle revealed a high wear after tattooing with ink containing titanium dioxide. The investigation of a skin biopsy obtained from a nickel sensitized patient with type IV allergy toward a tattoo showed both wear particles and iron pigments contaminated with nickel.
CONCLUSION
Previously, the virtually inevitable nickel contamination of iron pigments was suspected to be responsible for nickel-driven tattoo allergies. The evidence from our study clearly points to an additional entry of nickel to both skin and lymph nodes originating from tattoo needle wear with an as yet to be assessed impact on tattoo allergy formation and systemic sensitization.

Identifiants

pubmed: 31451117
doi: 10.1186/s12989-019-0317-1
pii: 10.1186/s12989-019-0317-1
pmc: PMC6710876
doi:

Substances chimiques

Coloring Agents 0
Chromium 0R0008Q3JB
titanium dioxide 15FIX9V2JP
Nickel 7OV03QG267
Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Références

An Bras Dermatol. 2013 Nov-Dec;88(6):925-8
pubmed: 24474101
Exp Dermatol. 2010 Jan;19(1):54-60
pubmed: 19703227
J Am Acad Dermatol. 1988 Aug;19(2 Pt 1):314-22
pubmed: 3170796
Br J Dermatol. 1991 Jun;124(6):576-80
pubmed: 2064942
Allergy. 2009 Aug;64(8):1157-65
pubmed: 19220218
Dermatology. 2013;226(2):138-47
pubmed: 23689478
J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S71-3
pubmed: 17052538
Part Fibre Toxicol. 2019 Aug 27;16(1):33
pubmed: 31451117
Small. 2011 May 23;7(10):1322-37
pubmed: 21520409
Toxicol Lett. 2009 Sep 28;189(3):177-83
pubmed: 19397964
Mol Microbiol. 2011 May;80(3):580-3
pubmed: 21375590
Sci Rep. 2017 Sep 12;7(1):11395
pubmed: 28900193
Rev Environ Health. 2006 Oct-Dec;21(4):253-80
pubmed: 17243350
Sci Total Environ. 2009 Nov 15;407(23):5997-6002
pubmed: 19766292
Bull NYU Hosp Jt Dis. 2009;67(2):182-8
pubmed: 19583551
Br J Dermatol. 2011 Dec;165(6):1210-8
pubmed: 21824122
J Bone Joint Surg Am. 2000 Apr;82(4):457-76
pubmed: 10761937
Arch Orthop Trauma Surg. 2004 Mar;124(2):104-13
pubmed: 14727127
Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2019 Feb;36(2):212-224
pubmed: 30696369
Contact Dermatitis. 2014 Nov;71(5):255-63
pubmed: 25040844
J Invest Dermatol. 2018 Dec;138(12):2687-2690
pubmed: 29935208
Curr Probl Dermatol. 2015;48:6-20
pubmed: 25833619
Lancet. 1969 Jul 5;2(7610):27-8
pubmed: 4182795
J Synchrotron Radiat. 2016 Jan;23(1):344-52
pubmed: 26698084
JAAD Case Rep. 2017 Jul 19;3(4):348-350
pubmed: 28761918
Dermatology. 2017;233(1):86-93
pubmed: 28486229
Contact Dermatitis. 2017 Dec;77(6):397-405
pubmed: 28795428
Dermatology. 2016;232(6):668-678
pubmed: 27974717
Biomaterials. 2007 Dec;28(34):5044-8
pubmed: 17645943
J Synchrotron Radiat. 2005 Jul;12(Pt 4):537-41
pubmed: 15968136

Auteurs

Ines Schreiver (I)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589, Berlin, Germany. ines.schreiver@bfr.bund.de.

Bernhard Hesse (B)

The European Synchrotron, CS 40220, 38043, Grenoble Cedex 9, France.
Xploraytion GmbH, Bismarckstrasse 10-12, 10625, Berlin, Germany.

Christian Seim (C)

Xploraytion GmbH, Bismarckstrasse 10-12, 10625, Berlin, Germany.
Department of X-ray Spectrometry, Physikalisch-Technische Bundesanstalt, Abbestrasse 2-12, 10587, Berlin, Germany.
Institute for Optics and Atomic Physics, Technical University Berlin, Hardenbergstrasse 36, 10623, Berlin, Germany.

Hiram Castillo-Michel (H)

The European Synchrotron, CS 40220, 38043, Grenoble Cedex 9, France.

Lars Anklamm (L)

Helmut Fischer GmbH Institut für Elektronik und Messtechnik, Industriestrasse 21, 71069, Sindelfingen, Germany.

Julie Villanova (J)

The European Synchrotron, CS 40220, 38043, Grenoble Cedex 9, France.

Nadine Dreiack (N)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589, Berlin, Germany.

Adrien Lagrange (A)

Xploraytion GmbH, Bismarckstrasse 10-12, 10625, Berlin, Germany.
Institute of Materials Science and Technologies, Technical University Berlin, Strasse des 17. Juni 135, 10623, Berlin, Germany.

Randolph Penning (R)

Institute of Forensic Medicine, Ludwig-Maximilians University, Nussbaumstrasse 26, 80336, Munich, Germany.

Christa De Cuyper (C)

Dermatology, Meiboomstraat 15, Blankenberge, 8370, Belgium.

Remi Tucoulou (R)

The European Synchrotron, CS 40220, 38043, Grenoble Cedex 9, France.

Wolfgang Bäumler (W)

Department of Dermatology, University of Regensburg, Franz Josef Strauß Allee 11, 93042, Regensburg, Germany.

Marine Cotte (M)

The European Synchrotron, CS 40220, 38043, Grenoble Cedex 9, France.
Laboratory of Molecular and Structural Archaeology (LAMS), Sorbonne University, CNRS, UMR8220, Paris, France.

Andreas Luch (A)

Department of Chemical and Product Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Strasse 8-10, 10589, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH